Clark Estates Inc Merck & Co., Inc. Transaction History

Clark Estates Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $11 Million - $12.4 Million	-150,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $7.23 Million - $9.05 Million	-100,000 Reduced 40.0%	150,000 $11.5 Million
Q2 2021 Aug 10, 2021	BUY	$70.31 - $77.77 $1.76 Million - $1.94 Million	25,000 Added 11.11%	250,000 $19.4 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $688,600 - $811,100	10,000 Added 4.65%	225,000 $17.3 Million
Q4 2020 Feb 09, 2021	BUY	$71.77 - $79.65 $2.51 Million - $2.79 Million	35,000 Added 19.44%	215,000 $17.6 Million

Q3 2020 Nov 05, 2020	BUY	$73.18 - $82.95 $1.46 Million - $1.66 Million	20,000 Added 12.5%	180,000 $14.9 Million
Q2 2020 Aug 05, 2020	BUY	$70.42 - $80.13 $7.75 Million - $8.81 Million	110,000 Added 220.0%	160,000 $12.4 Million
Q1 2020 Apr 28, 2020	BUY	$63.36 - $87.82 $3.17 Million - $4.39 Million	50,000 New	50,000 $3.85 Million

3,769

1.87B

17.3M

14.8M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $320B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Clark Estates Inc, based on Form 13F filings with the SEC.

Stay updated on Clark Estates Inc with notifications on news.